Diacerein, its beneficial impact on chondrocytes and notable new clinical applications
Sign Up to like & getrecommendations! Published in 2018 at "Brazilian Journal of Pharmaceutical Sciences"
DOI: 10.1590/s2175-97902018000417534
Abstract: Diacerein (DCN) was obtained by diacetylation of an anthraquinone derivative rhein and was approved by FDA in 2008, in the treatment of osteoarthritis due to its inhibitory effect on proinflammatory cytokines, including IL-6 and IL-1β.… read more here.
Keywords: diacerein beneficial; beneficial impact; notable new; treatment ... See more keywords